Endothelial Cell PAF Synthesis following Thrombin Stimulation Utilizes Ca2+-Independent Phospholipase A2
- 9 November 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 40 (49) , 14921-14931
- https://doi.org/10.1021/bi0156153
Abstract
Platelet activating factor (PAF) is a potent lipid autocoid that is rapidly synthesized and presented on the surface of endothelial cells following thrombin stimulation. PAF production may occur via de novo synthesis or by the combined direct action of phospholipase A2 (PLA2) and acetyl-CoA:lyso-PAF acetyltransferase or via the remodeling pathway. This study was undertaken to define the role of PLA2 and plasmalogen phospholipid hydrolysis in PAF synthesis in thrombin-treated human umbilical artery endothelial cells (HUAEC). Basal PLA2 activity in HUAEC was primarily found to be Ca2+-independent (iPLA2), membrane-associated, and selective for arachidonylated plasmenylcholine substrate. Thrombin stimulation of HUAEC resulted in a preferential 3-fold increase in membrane-associated iPLA2 activity utilizing plasmenylcholine substrates with a minimal increase in activity with alkylacyl glycerophospholipids. No change in cystolic iPLA2 activity in thrombin-stimulated HUAEC was observed. The thrombin-stimulated activation of iPLA2 and associated hydrolysis of plasmalogen phospholipids was accompanied by increased levels of arachidonic acid (from 1.1 ± 0.1 to 2.8 ± 0.1%) and prostacyclin release (from 38 ± 12 to 512 ± 24%) as well as an increased level of production of lysoplasmenylcholine (from 0.6 ± 0.1 to 2.1 ± 0.3 nmol/mg of protein), lysophosphatidylcholine (from 0.3 ± 0.1 to 0.6 ± 0.1 nmol/mg of protein), and PAF (from 790 ± 108 to 3380 ± 306 dpm). Inhibition of iPLA2 with bromoenol lactone resulted in inhibition of iPLA2 activity, plasmalogen phospholipid hydrolysis, production of choline lysophospholipids, and PAF synthesis. These data indicate that PAF production requires iPLA2 activation in thrombin-stimulated HUAEC and may occur through the CoA-independent transacylase remodeling pathway rather than as a direct result of the PLA2-catalyzed hydrolysis of membrane alkylacyl glycerophosphocholine.Keywords
This publication has 31 references indexed in Scilit:
- Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengersProstaglandins, Leukotrienes & Essential Fatty Acids, 1999
- Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A2: structure-function studies with vesicle, micelle, and membrane assays1This paper is dedicated to the memory of Prof. H.M. Verheij.1Biochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- Irreversible inhibition of Ca2+-independent phospholipase A2 by methyl arachidonyl fluorophosphonateBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Platelet-Activating Factor Produced by Endothelial Cells. A Molecule with Autocrine and Paracrine PropertiesEuropean Journal of Biochemistry, 1995
- Platelet-activating factor and its analogs: metabolic pathways and related intracellular processesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion.The Journal of cell biology, 1990
- Adherence of human basophils to cultured umbilical vein endothelial cells.Journal of Clinical Investigation, 1988
- Endothelium from diverse vascular sources synthesizes platelet-activating factor.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.Journal of Clinical Investigation, 1985
- A new micromethod for the colorimetric determination of inorganic phosphateClinica Chimica Acta; International Journal of Clinical Chemistry, 1966